Wave Life Sciences Ltd. - Ordinary Shares (WVE) Social Stream
Wave Life Sciences Ltd (WVE) Price Targets From Analysts
Use the tables below to see what analysts covering Wave Life Sciences Ltd think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 7 | $17 | $6 | $9.86 | $4.85 | 103.3% |
The Trend in the Analyst Price Target
Over the past 58 days, WVE's average price target has gone up $0.72.
Over the past 16 months, WVE's average upside potential has been 62.32%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-20 | 7 | 17 | 6 | 9.86 | 5.600 | 76.07% |
| 2021-09-19 | 7 | 17 | 6 | 9.86 | 5.680 | 73.59% |
| 2021-09-18 | 7 | 17 | 6 | 9.86 | 5.680 | 73.59% |
| 2021-09-11 | 7 | 17 | 6 | 9.86 | 6.050 | 62.98% |
| 2021-09-04 | 7 | 17 | 6 | 9.86 | 6.230 | 58.27% |
| 2021-08-17 | 7 | 17 | 6 | 9.86 | 6.310 | 56.26% |
| 2021-08-14 | 7 | 17 | 6 | 9.86 | 6.410 | 53.82% |
| 2021-08-07 | 7 | 17 | 6 | 9.14 | 5.940 | 53.87% |
| 2021-08-05 | 7 | 17 | 6 | 9.14 | 6.030 | 51.58% |
| 2021-08-01 | 7 | 17 | 6 | 9.14 | 5.510 | 65.88% |
| 2021-07-24 | 7 | 17 | 6 | 9.14 | 5.840 | 56.51% |
| 2021-07-17 | 7 | 17 | 6 | 9.14 | 6.650 | 37.44% |
| 2021-07-01 | 7 | 17 | 6 | 9.14 | 6.740 | 35.61% |
| 2021-06-26 | 7 | 17 | 6 | 9.14 | 7.050 | 29.65% |
| 2021-06-13 | 7 | 17 | 6 | 9.14 | 7.240 | 26.24% |
| 2021-05-26 | 7 | 17 | 6 | 9.00 | 6.780 | 32.74% |
| 2021-05-22 | 7 | 17 | 6 | 9.00 | 6.850 | 31.39% |
| 2021-05-15 | 7 | 17 | 7 | 9.14 | 6.210 | 47.18% |
| 2021-05-08 | 7 | 17 | 7 | 9.14 | 6.080 | 50.33% |
| 2021-04-25 | 7 | 17 | 7 | 9.14 | 6.070 | 50.58% |
| 2021-04-15 | 7 | 17 | 7 | 9.14 | 6.340 | 44.16% |
| 2021-04-10 | 7 | 17 | 7 | 9.14 | 6.230 | 46.71% |
| 2021-04-03 | 7 | 17 | 7 | 9.14 | 6.090 | 50.08% |
| 2021-03-08 | 7 | 27 | 7 | 16.57 | 9.920 | 67.04% |
| 2021-03-06 | 7 | 27 | 7 | 16.57 | 9.440 | 75.53% |
| 2021-02-27 | 7 | 27 | 7 | 16.57 | 9.410 | 76.09% |
| 2021-02-20 | 7 | 27 | 7 | 16.57 | 10.110 | 63.9% |
| 2021-02-13 | 7 | 27 | 7 | 16.57 | 10.690 | 55% |
| 2021-02-06 | 7 | 27 | 7 | 16.57 | 11.555 | 43.4% |
| 2021-01-30 | 7 | 27 | 7 | 16.57 | 10.170 | 62.93% |
| 2021-01-12 | 7 | 27 | 7 | 16.57 | 9.310 | 77.98% |
| 2021-01-09 | 7 | 27 | 7 | 16.57 | 10.350 | 60.1% |
| 2021-01-02 | 7 | 27 | 7 | 16.57 | 7.870 | 110.55% |
| 2020-12-26 | 7 | 27 | 7 | 16.57 | 8.910 | 85.97% |
| 2020-12-19 | 7 | 27 | 7 | 16.57 | 8.410 | 97.03% |
| 2020-12-10 | 7 | 27 | 7 | 16.57 | 9.020 | 83.7% |
| 2020-12-07 | 7 | 27 | 7 | 16.57 | 8.620 | 92.23% |
| 2020-11-19 | 7 | 27 | 7 | 16.57 | 8.770 | 88.94% |
| 2020-11-09 | 7 | 27 | 7 | 16.86 | 7.480 | 125.4% |
| 2020-10-21 | 7 | 27 | 8 | 17.00 | NA | NA% |
| 2020-09-18 | 6 | 27 | 8 | 17.67 | NA | NA% |
| 2020-07-20 | 6 | 21 | 8 | 16.50 | NA | NA% |
| 2020-05-20 | 7 | 21 | 8 | 16.71 | NA | NA% |
WVE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.64 | 1 | 3 | 3 | 0 | 0 | 7 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for WVE as an investment opportunity.
- The variance in analysts' estimates of WVE is lower than 3.47% of all US stocks.
- The number of analysts covering the stock of WVE is higher than 87.94% of stocks in the small market cap category.
- Wave Life Sciences Ltd's upside potential (average analyst target price relative to current price) is greater than 81.9% of all US stocks.
- Wave Life Sciences Ltd's average analyst price target is greater than 18.36% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Wave Life Sciences Ltd are RYTM, UBX and CLSD.
What is the outlook for WVE? Use POWR Ratings for clearer insight into price direction.